Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.83 |
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.83 |
| ▸ | TYR | P14679 | 2/20 | 0.55 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.46 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.46 |
| ▸ | TST | Q16762 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | MANBA | O00462 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | CDC25C | P30307 | 1/20 | 0.31 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ascorbic Acid SCHEMBL5033864 | 0.94 | MAPT (0.78) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL30461160 | 0.93 | MAPT (0.96) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL734589 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL2564750 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL785 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL786 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL10957988 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL11981759 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL21114349 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 | |
| Ascorbic Acid SCHEMBL18678 | 0.91 | MAPT (1.00) | MAPTLMNAL3MBTL1TYRHSPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030198657-A1 | Methods using phytol to improve the appearance of skin and compositions for such methods | AVON PRODUCTS, INC. | 2003-10-23 | — | — | US | disclosed |
| EP-1261314-A4 | METHODS USING PHYTOL TO IMPROVE THE APPEARANCE OF SKIN AND COMPOSITIONS FOR SUCH METHODS | AVON PROD INC (US) | 2003-06-11 | — | — | EP | disclosed |
| EP-1261314-A1 | METHODS USING PHYTOL TO IMPROVE THE APPEARANCE OF SKIN AND COMPOSITIONS FOR SUCH METHODS | AVON PRODUCTS, INC. (US) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001066080-A1 | METHODS USING PHYTOL TO IMPROVE THE APPEARANCE OF SKIN AND COMPOSITIONS FOR SUCH METHODS | AVON PRODUCTS, INC. (US) | 2001-09-13 | — | — | WO | disclosed |
| US-4803991-A | Three electrode hydroquinone subcutaneous equilibrating tonometer | BAXTER HEALTHCARE CORPORATION (US) | 1989-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030198657-A1 | Methods using phytol to improve the appearance of skin and compositions for such methods | CUTA, RARA, RXRA | MAPT 3738/4885LMNA 368/4885L3MBTL1 3720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.